Come and meet us at the following events...
October 20-22nd 2010 - Well Characterized Biologicals - Hyatt Regency Bethesda, Bethesda, MD
September 21-23rd 2010 - Formulation Strategies in Protein Therapeutics - Providence Convention Center, Providenc, RI
June 17-18th 2010 - Protein Formulation Development Forum - Barcelona, Spain
May 19-20th 2010 - Bioprocess International - Vienna, Austria
Avacta Analytical's Chief Science Officer, Simon Webster, is delivering a spotlight presentation "Biophysical analysis as a vital and versatile tool in formulation development".
May 17-21st 2010 - PEGS 7 - Boston, USA
April 13-15th 2010 - Biopharmaceutical Change Control Conference - Hilton San Diego Resort
Avacta Analytical Director of Sales and Marketing, James Wilson, is delivering a Spotlight Presentation titled "Scale down analytics for early stage screening and design space determination: 'manufacturability by design'".
January 14-15th 2010 - Second Annual Immunogenicity Meeting - Barcelona, Spain
Avacta's Head of Analytical Services, Inigo Rodriguez-Mendieta, will give a spotlight presentation: “Denaturation and Aggregation of Protein Therapeutics – A Red Flag to Immune Reactions?"
November 25-26th 2009 - Bioprocess UK - York, UK
October 27-28th 2009 - BioProduction2009 - Barcelona, Spain
Avacta's CSO, Simon Webster, will give a spotlight presentation: “Miniaturisation - Improving Sensitivity of Analytical Systems"
May 17-20th - Bio2009 - Atlanta, USA
April 22-23rd - Bio-process International 2009 - Dusseldorf, Germany
Acquisition of Veterinary Diagnostics Company
Acute Phase Protein Tests Expands Avacta Animal Health Offering
03.03.2010
Avacta Group plc Placing
Target of becoming a substantial and profitable business supporting the life sciences sector is on track.
21.10.2009
Optim - Second Order
Momentum builds for flagship technology - Optim: huge annual revenues opportunity
07.10.2009
Optim Commercial Success
Avacta announces commercial success for its recently launched flagship product, Optim.
28.09.2009